BioWales is one of the UK’s largest life sciences conferences and brokerage events held outside of London. The 2-day conference will consider if the existence of a centralised health service, such as the NHS, allows for a faster co-ordinated process of providing industry with access to clinical expertise.
The conference programme will cover the medical devices sector, big pharma, industry advisors, academia, funding organisations, Government and clinicians. A line up of top speakers includes international sector names such as biotech entrepreneur Professor Sir Chris Evans, the Founder and Chairman of the Excalibur Group, who also heads up the Wales Life Sciences Sector Panel, and Professor Andrew Barron, former Professor of Chemistry at Harvard University and now Charles W. Duncan Jr. – Welch Chair of Chemistry and Professor of Materials Science at Rice University.
Sir Chris Evans is leading the push to create a life science cluster that maximises local skills and growth potential in Wales. At BioWales 2012 he launched a £100m package of funding, half of it granted by Welsh Government, to support life sciences enterprise growth. Sir Chris said: “Welsh life sciences have reached a watershed. Wales is right now pursuing a unique model in setting up a hub and a fund to create the brand, and BioWales 2013 gives us the chance to bring the industry together in Cardiff to see how Wales is developing as a cluster.”
The international exhibition boasts over 35 businesses from the UK and the brokerage features one-to-one meetings between companies and organizations to foster collaboration and sales. There is also a Gala Dinner with entertainment in the magnificent setting of Wales’ iconic arts venue.
Any delegates registering before January 19 will benefit from a 50% discount in the registration fee. See www.biowales.com for details.
The event reflects the significance of the life sciences sector in Wales, represented by some 330 companies, employing over 15,000 people and contributing more than £1.3bn to the Welsh economy.